Merck & Co., Inc. (MRK) Stock Analysis

Merck & Co., Inc. (MRK) Stock Analysis — AI Research | MarketCI

MRK

Market Closed

Merck & Co., Inc.

NYSEHealthcare Drug Manufacturers - General

73.00K employees

CEO: Robert Davis

Founded: 1978

$113.87

+$0.00(+NaN%)

Market Cap

281.24B

Beta

0.22

52W Range

N/A

Dividend Yield

2.95%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

MRK Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for MRK built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$204.04

AI Price Target

Machine learning • Price prediction

$111.60

Market Sentiment

News & social media analysis

0.22

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

3.80

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting MRK investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

80.49% Excellent

Conditions Met

33.00/41.00

Due Diligence Score

80.49%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions